The U.K.’s Joint Committee on Vaccination and Immunisation (JCVI) has been considering a potential move to authorize just one dose of the HPV vaccine for several years.
Indeed, the JCVI was aware of the potential for one dose as far back as 2018.
The committee agreed in February 2022 that there is now enough clinical evidence to advise a change in the schedule from two doses of 4-valent HPV vaccine to one dose in the routine adolescent program for those up to 14 years of age.
Read More
